Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A Significant Portion Of Our Investments Are Currently Illiquid

A Significant Portion Of Our Investments Are Currently Illiquid, Which May Impact Our Acquisition Strategy And/Or Operating Results

What would you expect PTSC to say when they are suing for damages?

.

.

.

Be well

Share
New Message
Please login to post a reply